Search Results - "Lancar, R"

Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma by Haie-Meder, C, Kramar, A, Lambin, P, Lancar, R, Scalliet, P, Bouzy, J, Gerbaulet, A

“…The analysis of complications in a prospective randomized trial comparing two preoperative brachytherapy low-dose rates in early stage cervical cancer is…”
Get more information

Risk Factors for Seborrhoeic Dermatitis Flares: Case-control and Case-crossover Study by Lancar, R, Missy, P, Dupuy, A, Beaulieu, P, Fardet, L, Costagliola, D, Chosidow, O

“…Patients with flares of seborrhoeic dermatitis were compared with control outpatients seen during the same time-period in a case-control study, and with…”
Get full text

Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study by Musset, Dominique, Parent, Florence, Meyer, Guy, Maître, Sophie, Girard, Philippe, Leroyer, Christophe, Revel, Marie-Pierre, Carette, Marie-France, Laurent, Marcel, Charbonnier, Bernard, Laurent, François, Mal, Hervé, Nonent, Michel, Lancar, Rémi, Grenier, Philippe, Simonneau, Gerald

“…We designed a prospective multicentre outcome study to evaluate a diagnostic strategy based on clinical probability, spiral CT, and venous compression…”
Get full text

Alpha interferon administration during structured interruptions of combination antiretroviral therapy in patients with chronic HIV-1 infection: INTERVAC ANRS 105 trial by BOUE, François, REYNES, Jacques, ROUZIOUX, Christine, EMILIE, Dominique, SOUALA, Faouzi, TUBIANA, Rolland, GOUJARD, Cécile, LANCAR, Rémi, COSTAGLIOLA, Dominique

“…Interferon-α administration during structured treatment interruptions (STIs) was studied in a phase III trial. We randomized 168 chronically infected HIV…”
Get full text

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor by GRABAR, S, PRADIER, C, COSTAGLIOLA, D, LE CORFEC, E, LANCAR, R, ALLAVENA, C, BENTATA, M, BERLUREAU, P, DUPONT, C, FABBRO-PERAY, P, POIZOT-MARTIN, I

“…To determine the predictors of virological and clinical failure in patients receiving a protease inhibitor as part of triple therapy. From the French Hospital…”
Get full text

Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection by BRUSSEL, Audrey, MATHEZ, Dominique, BROCHE-PIERRE, Sophie, LANCAR, Rémi, CALVEZ, Thierry, SONIGO, Pierre, LEIBOWITCH, Jacques

“…To evaluate the potential use of 2-long terminal repeats (LTR) HIV circular DNA quantification for the monitoring of ongoing virus replication in treated…”
Get full text

Lymph node prognostic factors in head and neck squamous cell carcinomas by Mamelle, G, Pampurik, J, Luboinski, B, Lancar, R, Lusinchi, A, Bosq, J

“…This retrospective study included 914 patients who underwent a lymph node dissection at our institute between 1980 and 1985. The primary tumor sites were oral…”
Get more information

Facteurs de risque de dermatite séborrhéique : étude cas-témoins et cas-croisé. Étude EPIDERMAS by Missy, P., Lancar, R., Dupuy, A., Beaulieu, P., Fardet, L., Costagliola, D., Chosidow, O.

“…Les facteurs étiologiques de dermatite séborrhéique (DS) sont mal connus et les facteurs de risque de poussée n’ont jamais été formellement identifiés. Les…”
Get full text

Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients by Anduze-Faris, B M, Fillet, A M, Gozlan, J, Lancar, R, Boukli, N, Gasnault, J, Caumes, E, Livartowsky, J, Matheron, S, Leport, C, Salmon, D, Costagliola, D, Katlama, C

“…To evaluate the efficacy and safety of the foscarnet-ganciclovir combination in induction therapy (IT) and maintenance therapy (MT) for cytomegalovirus (CMV)…”
Get full text

Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection by Brussel, A, Mathez, D, Broche-Pierre, S, Lancar, R, Calvez, T, Sonigo, P, Leibowitch, J

“…Objective: To evaluate the potential use of 2-long terminal repeats (LTR) HIV circular DNA quantification for the monitoring of ongoing virus replication in…”
Get full text

112Principle methods for the evaluation of late complications by Kramar, A., Lancar, R.

Get full text

Predictors of medical events and of their competitive interactions in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2) by Funck-Brentano, Christian, Lancar, Rémi, Hansen, Sören, Hohnloser, Stefan H., Vanoli, Emilio

“…Aims Predictive factors for medical events and interactions between events were not reported in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2). We…”
Get full text

Efficacy and tolerability of Stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection by KATLAMA, C, VALANTIN, M.-A, LANCAR, R, AGUT, H, BRUN-VEZINET, F, COSTAGLIOLA, D, MATHERON, S, COUTELLIER, A, CALVEZ, V, DESCAMPS, D, LONGUET, C, BONMARCHAND, M, TUBIANA, R, DE SA, M

“…A combination of two nucleoside analogues is currently the core of any antiretroviral regimen for HIV-1 infection. Stavudine plus lamivudine has shown an…”
Get full text

Time to AIDS From 1992 to 1999 in HIV-1-Infected Subjects With Known Date of Infection by Tassie, Jean-Michel, Grabar, Sophie, Lancar, Rémi, Deloumeaux, Jacqueline, Bentata, Michèle, Costagliola, Dominique

“…To estimate the change in AIDS incubation time during three periods characterized by different availability of antiretroviral treatments, data from the French…”
Get full text

Robust analysis methods for multivariate survival times by Lancar, R

“…In a long term clinical study, the subjects may experience repeated occurrences of the same type of events or multiple events of entirely different nature…”
Get more information

Predictors of medical events in patients enrolled in the cardiac insufficiency bisoprolol study (CIBIS): A study of the interactions between β-blocker therapy and occurrence of critical events using analysis of competitive risks by Funck-Brentano, Christian, Lancar, Rémi, Le Heuzey, Jean-Yves, Lardoux, Hervé, Soubrié, Claudine, Lechat, Philippe

“…Background The risk of occurrence of medical events in a clinical trial is competitive in nature; that is, in a given patient the risk of having a critical…”
Get full text

Predictors of medical events in patients enrolled in the Cardiac Insufficiency Bisoprolol Study (CIBIS): A study of the interactions between [beta ]-blocker therapy and occurrence of critical events using analysis of competitive risks by Funck-Brentano, Christian W., Lancar, R[eacute]mi W., Le Heuzey, Jean-Yves W., Lardoux, Herv[eacute] W., Soubri[eacute], Claudine W., Lechat, Philippe W.

Get full text

Non-parametric methods for analysing recurrent complications of varying severity by Lancar, R, Kramar, A, Haie-Meder, C

“…Non-parametric methods have recently been proposed to take into account the recurrent nature of complications in clinical trials, by estimating the prevalence…”
Get more information

638 Lymph node dissection in head and neck cancer—modalities, prognostic value by Luboinski, B., Mamelle, G., Julieron, M., Pampurik, J., Lancar, R., Casiraghi, O., Eschwege, F., Schwaab, G.

“…Radical neck dissection (RND) was first described by Crile in 1906 about 132 procedures. A large variety of modified neck-dissections have been proposed during…”
Get full text

393 Induction chemotherapy before radiotherapy in oropharyngeal carcinoma. A randomized trial by Domenge, C., Lancar, R., Coche-Dequeant, B., Lusinchi, A., Lefebvre, J.L., Marandas, P., Eschwege, F., Sancho-Gamier, H., Luboinski, B.

“…From 2/86 till 3/91 at Institut Gustave-Roussy in Villejuif and at Oscar Lambret Cancer Center in Lille 166 patients with squamous cell carcinoma of oropharynx…”
Get full text